Company Data

Anebulo Pharmaceuticals Inc.

Ticker
ANEB
Current Price
$1.33
Market Cap
$34.5M
Price Target
Refer to Report
Volume
1.7K
52wk Range
$0.8001 - $3.3
Advanced Market Data

Overview

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy